Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

After-Hours Stock Movers 03/30: (OEG) (PRG) (CORT) Higher; (PATH) (EXFY) (MASI) Lower (more...)

Published 31-03-2022, 03:02 am
NDX
-
CCJ
-
CDXS
-
CORT
-
MASI
-
OIGBQ
-
FRGI
-
AFMD
-
PRG
-
PATH
-
EXFY
-

After-Hours Stock Movers:

UiPath Inc. (PATH) 20% LOWER; reported fourth-quarter EPS of $0.05, versus the consensus of $0.03. Revenue for the quarter came in at $289 million versus the consensus estimate of $283.03 million. Looking for Q1 2023 revenue of $223-225 million, below the consensus of $243.1 million.

Expensify, Inc. (EXFY) 17% LOWER; reported fourth-quarter EPS of ($0.82), below the consensus of $0.08. Revenue for the quarter came in at $40.4 million versus the consensus estimate of $38.79 million. The company guided Q1 2022 revenue to $38.6-39.6 million, versus the consensus of $40.34 million.

Orbital Energy Group, Inc. (OEG) 15% HIGHER; Q4 revenue rose 65% to $41 million versus the consensus estimate of $45.02 million. It also reported a record backlog of $523.7 million.

Masimo (NASDAQ:MASI) Corporation (Nasdaq: MASI) 10% LOWER; sees product revenue for the first quarter between $285 million to $315 million, below the consensus of $329.7 million. They cited shortages of critical components and other supply chain issues.

PROG Holdings Inc. (PRG) 6% HIGHER; to replace Fiesta (NASDAQ:FRGI) Restaurant Group Inc. (FRGI) in the S&P SmallCap 600.

Corcept Therapeutics Incorporated (NASDAQ:CORT) 3% HIGHER; announced overall survival data from Phase 2 study of relacorilant plus nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer, showing 33% reduction in risk of death.

Affimed Therapeutics (NASDAQ:AFMD) 2% HIGHER; Piper Sandler initiates the stock with an Overweight rating and $7 price target.

Cameco Corp . (NYSE:CCJ) 1% HIGHER; BMO Capital upgraded shares to Outperform with a price target of C$42, saying the stock should continue to benefit from momentum for low carbon nuclear generation.

Codexis , Inc. (NASDAQ:CDXS) 1% HIGHER; Piper Sandler initiated coverage with an Overweight rating and a price target of $35.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.